InVitroCare's Polyvinylpyrrolidone (PVP) reagent is composed of polyvinylpyrrolidone (MW:360,000) dissolved in a combined sodium bicarbonate/HEPES…
InVitroCare’s Polyvinylpyrrolidone (PVP) reagent is composed of polyvinylpyrrolidone (MW:360,000) dissolved in a combined sodium bicarbonate/HEPES ([4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid]) buffering system and is appropriate for those procedures that do not use a carbon dioxide atmosphere. PVP is intended for use as a medium for the immobilization and isolation of single sperm cells during intracytoplasmic sperm injection (ICSI) procedures.
Who Else Makes It
Concentrated in Guangdong (3), Shandong (1).
Record
Regulatory record for PVP – Polyvinylpyrrolidone | Listed by | Invitrocare Inc, United States |
| FDA product code | MQL |
| Device type | Media, Reproductive |
| Device class | Class 2 |
| Regulation | 21 CFR 884.6180 |
| Establishment | Repacker / relabeller, Manufacturer |
| 510(k) | K001967 |
| Record published | 2016-09-24 |
| Record revised | 2018-07-06 (version 3) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Supplied sterile | Yes |
| Single use | Yes |
| Label carries | lot or batch number, expiry date |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.